NCT00407589View on ClinicalTrials.gov

Systemic Pharmacokinetics of BOL-303224-A

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Conjunctivitis, Bacterial
Interventions
DRUG

BOL-303224-A

1 drop in each eye, TID for 5 days at approximately 6 h intervals, with a final, single dose on the morning of Visit 7 (Day 6).

Trial Locations (1)

27262

Cornerstone Eyecare, High Point

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00407589 - Systemic Pharmacokinetics of BOL-303224-A | Biotech Hunter | Biotech Hunter